SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Meem, Manila |
---|---|
Outros Autores: | Akter, Dr. Raushanara |
Formato: | Tese |
Idioma: | English |
Publicado em: |
Brac University
2023
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/18081 |
Registros relacionados
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
por: Islam, Saidul
Publicado em: (2022) -
RIPK pathway, as a potential target, for cancer treatment - a review
por: Jahan, Nusrat
Publicado em: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
por: Flora, Sanzida Alam
Publicado em: (2024) -
Immunotherapy in the Management of Lung Cancer
por: Tasnim, Humayra
Publicado em: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
por: Ratu, Tabassum
Publicado em: (2024)